Navigation Links
Telecommunications Carriers Respond To Congress' Declaration of April as National 9-1-1 Education Month
Date:4/3/2008

Leading Emergency Stand Alone switch provider sees telcos looking to find viable solutions for improving public safety and network resiliency for all

Americans

BOULDER, Colo., April 3, 2008 /PRNewswire-USNewswire/ --

WHO: Steven Bruny

CEO

Aztek Networks (http://www.azteknetworks.net)

A veteran in the telecommunications industry with more than

20 years experience, Bruny has served as CEO of Aztek Networks,

the leader in Emergency Stand Alone (ESA) equipment for enabling

network switch collapse since June of 2006. Prior to being named

to his current post, Bruny was president of the Americas for

Azure Solutions, the world leader in revenue assurance and fraud

software for the telecom industry. Azure was acquired by Subex

Systems, Ltd., in June of 2006. Bruny was the Founder and COO of

Connexn Technologies, Inc., a leading provider of revenue

assurance software to the telecom industry which was acquired by

Azure in 2004. Prior to Connexn, he was CEO of IGS, a telecom

network facilities inventory company funded by Warburg Pincus.

Bruny also was founder and CEO of Information + Graphics

Systems, a telecom and utilities software provider that was

acquired by Hitachi Software Engineering in 1993, and President

of Optical Computer, a division of American Laser Corporation.

Bruny holds a B.S. degree in physics from Colorado State

University and a M.B.A. from the University of Colorado.

WHAT: While most people know to call 9-1-1 in an emergency situation

not everyone is aware of the limitations of the system given t
'/>"/>

SOURCE Aztek Networks
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Telecommunications Technology Boosts Revenue Generation by Billions and Builds Positive Brand Experience
2. Jopari Ramps Up Texas eBill Production With National and Regional Carriers and Medical Billing Technology Suppliers
3. Mitchell Medical and Jopari Solutions Team up to Offer eBilling Compliance Services to Automobile Property & Casualty Insurance Carriers to Meet New Minnesota Requirements
4. Life Brokerage Partners Adds New Insurance Carriers
5. Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers
6. The Toy Industry Association Responds to Washington State Law Governing the Sale of Toys and the Governors Veto of Key Sections of the Bill
7. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
8. DRAXIS Responds to Trading
9. Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
10. Maternal love: How a mothers brain responds to her infant
11. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 1NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 2NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 3NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test 52659 4SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 1SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 2SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 3SAPHRIS 28R 29 28asenapine 29 Meets Primary Endpoint in Long Term Extension Study in Patients With Predominant Persistent Negative Symptoms of Schiz 13189 4Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 1Terumo Cardiovascular Systems Initiates U S Clinical Trial for Anaconda 28TM 29 AAA Stent Graft System 4777 2